Back to Markets
Commodities● Neutral
$BIOX Raises FY2026 Guidance as HB4 Wheat Acres Hit 1.2M
Revenue of $105.2M (+22% YoY) and adjusted EBITDA of $28.4M (27% margin) drove the raise. Full-year revenue now seen at $400-$410M, with HB4 wheat planted area reaching 1.2M hectares.
Continue with
Bioceres Crop Solutions raised its full-year fiscal 2026 revenue and profit outlook after third-quarter results showed accelerating adoption of its drought-tolerant HB4 wheat and expanding margins in biologicals. The company now sees revenue of $400 million to $410 million, up from a prior range of $380 million to $400 million, and adjusted EBITDA of $100 million to $105 million, up from $90 million to $100 million.
Guidance Raise to $400-$410M
The revised forecast follows a quarter where total revenue reached $105.2 million, a 22% increase from the same period a year earlier. Adjusted EBITDA came in at $28.4 million, producing a 27% margin that improved from 24% in the prior-year quarter. Net income attributable to Bioceres was $6.1 million, or $0.09 per diluted share.
The simple read is that a guidance raise confirms strong demand. The better market read is that the raise was already partially discounted after two consecutive quarters of HB4 acreage gains. The stock’s reaction will hinge on whether the new midpoint of $405 million in revenue and $102.5 million in EBITDA implies a re-rating of the multiple or merely catches up to sell-side models that had drifted above the old range.
HB4 Wheat Planted Area Jumps to 1.2M Hectares
The structural driver behind the raise is the expansion of HB4 wheat, the company’s genetically modified drought-tolerant seed. Planted area in Argentina reached 1.2 million hectares during the season, up from 800,000 hectares a year earlier. That 50% increase signals that growers are committing acreage to a technology that lowers yield risk in a region where weather variability can swing farm income sharply.